Salvage chemotherapy with CPT-11 for recurrent temozolomide-refractory anaplastic oligodendroglioma

被引：0
|
作者：
Chamberlain, Marc
Wei-tsao, Denice
Chowdhary, Sajeel
Blumenthal, Deborah
Glantz, Michael
机构：
来源：
NEUROLOGY | 2007年 / 68卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A93 / A93
页数：1
相关论文
共 50 条
  • [31] Irinotecan (CPT-11) combined with cisplatin in patients with refractory or recurrent ovarian cancer
    Sugiyama, T
    Yakushiji, M
    Nishida, T
    Ushijima, K
    Okura, N
    Kigawa, J
    Terakawa, N
    CANCER LETTERS, 1998, 128 (02) : 211 - 218
  • [32] Salvage Chemotherapy with Bevacizumab for Recurrent Alkylator-Refractory Anaplastic Astrocytoma
    Chamberlain, Marc C.
    Johnston, Sandra K.
    NEUROLOGY, 2009, 72 (11) : A111 - A112
  • [33] Salvage chemotherapy with bevacizumab for recurrent alkylator-refractory anaplastic astrocytoma
    Marc C. Chamberlain
    Sandra Johnston
    Journal of Neuro-Oncology, 2009, 91 : 359 - 367
  • [34] Salvage chemotherapy with bevacizumab for recurrent alkylator-refractory anaplastic astrocytoma
    Chamberlain, Marc C.
    Johnston, Sandra
    JOURNAL OF NEURO-ONCOLOGY, 2009, 91 (03) : 359 - 367
  • [35] Salvage therapy with lomustine for temozolomide refractory recurrent anaplastic astrocytoma: A retrospective study.
    Chamberlain, Marc C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [36] Bevacizumab for Recurrent Alkylator-Refractory Anaplastic Oligodendroglioma
    Chamberlain, Marc C.
    Johnston, Sandra
    CANCER, 2009, 115 (08) : 1734 - 1743
  • [37] Salvage therapy with bendamustine for temozolomide refractory recurrent anaplastic gliomas: a prospective phase II trial
    Chamberlain, Marc C.
    Colman, Howard
    Kim, Bryan T.
    Raizer, Jeffrey
    JOURNAL OF NEURO-ONCOLOGY, 2017, 131 (03) : 507 - 516
  • [38] Salvage therapy with bendamustine for temozolomide refractory recurrent anaplastic gliomas: a prospective phase II trial
    Marc C. Chamberlain
    Howard Colman
    Bryan T. Kim
    Jeffrey Raizer
    Journal of Neuro-Oncology, 2017, 131 : 507 - 516
  • [39] Temozolomide single-agent chemotherapy for newly diagnosed anaplastic oligodendroglioma
    T. Mikkelsen
    T. Doyle
    J. Anderson
    J. Margolis
    N. Paleologos
    J. Gutierrez
    D. Croteau
    L. Hasselbach
    R. Avedissian
    L. Schultz
    Journal of Neuro-Oncology, 2009, 92 : 57 - 63
  • [40] Temozolomide single-agent chemotherapy for newly diagnosed anaplastic oligodendroglioma
    Mikkelsen, T.
    Doyle, T.
    Anderson, J.
    Margolis, J.
    Paleologos, N.
    Gutierrez, J.
    Croteau, D.
    Hasselbach, L.
    Avedissian, R.
    Schultz, L.
    JOURNAL OF NEURO-ONCOLOGY, 2009, 92 (01) : 57 - 63
12345